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Abstract 
Objective: To review the evidence for using technology to improve access to 
specialist care for patients with amyotrophic lateral sclerosis (ALS) and their carers. 
Methods: Medline, Google Scholar and the Cochrane library were searched for 
articles describing technology that enabled clinical care of patients with ALS or their 
carers where the patient/carer and clinician were not in the same location. 
Results: Two applications were identified: telemedicine to facilitate video 
conferencing as an alternative to outpatient consultations and telehealth monitoring 
for patients with respiratory failure.  One randomised controlled trial using telehealth 
in patients with respiratory failure including 22 patients with ALS was identified.  
Whilst rates of hospitalisation were reduced, overall mortality was unchanged and 
there were too few patients with ALS in the study to detect significant benefit.    
Conclusion: There is limited evidence to support use of telemedicine or telehealth in 
the care of patients with ALS.   Future research needs to develop an understanding of 
the key beneficial aspects of the traditional specialist ALS service and how these 
factors could be delivered using technology. Successful evaluation and 
implementation of technologies to facilitate access to specialist care will only be 
possible if all the relevant impacts of an intervention are understood and measured.  
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Introduction 
Management of a patient with amytrophic lateral sclerosis (ALS) aims to improve 
quality of life and survival. Riluzole and non-invasive ventilation (NIV) can prolong 
life but attendance at a specialist multidisciplinary ALS clinic is also independently 
associated with improved survival and quality of life although the reasons for this are 
uncertain (1-5).  Patients must travel to access these specialist services that are usually 
based in cities.  These services often differ from those available locally, particularly in 
rural areas.   Given the low prevalence of ALS (approximately 5.4 per 100 000) 
specialists cover a large geographical area and as a result, much of the day-to-day care 
is provided by non-specialists (6,7). In Scotland for example, six specialist nurses care 
for 300-400 patients covering an area of over 78 000km2 (8).   Lack of expertise and 
limited access to specialist staff and equipment causes patients and their carers to 
experience significant difficulties (9-14).  Whilst in the UK approximately 70% of 
patients attend a specialist clinic at some point in their illness, patients experience 
difficulties travelling to clinic as well as the long duration of clinic visits (15,16). As 
they become more frail it often becomes impossible for them to attend the clinic and 
may lose the benefits offered by the specialist service. 
 
Technologies that enable patients to access health services from their home are now 
used in many diseases.  These include telemedicine (video conferencing), telehealth 
(remote monitoring of measurements such as oxygen saturations or patient 
symptoms), telecoaching (mentoring using phone or video) and telecare (technology 
to support independent living e.g. falls monitors).  Other expanding areas include 
health ÒappsÓ, internet based education, peer support and the storage and sharing of 
medical records (17-19).   Video conferencing has been used in neurology outpatient 
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settings, extensively in acute stroke thrombolysis and in palliative care, but evidence 
to recommend its use is limited (20-26).   
 
Trials of telehealth in long-term conditions such as lung disease and cardiac failure 
have suggested that telehealth may be an acceptable way to improve access to 
specialist care and facilitate self-management.  Reductions in mortality, decreased 
hospital admissions and reduced healthcare costs have been reported but benefits tend 
to be small and of limited clinical significance (27-29).  Two large studies of 
telehealth reported increased mortality (30,31).  One study suggested that the excess 
mortality could be due to an increase in healthcare interventions triggered by the 
telehealth monitoring (31).  The other study suggested that the intervention (a self-
management programme) could have resulted in a detrimental change in patientsÕ 
behaviour but, it was not possible to evaluate how the intervention was implemented 
at each site, or whether this resulted in the excess mortality (30).  This highlights the 
limitations of using only standard randomised controlled trials to evaluate complex 
telehealth interventions: without fully understanding how the intervention brings 
about change it is not possible to explain unanticipated effects (32). 
 
A small number of studies using telehealth in chronic disease (e.g. asthma and heart 
disease) have demonstrated improvements in quality of life but many found little or 
no benefit (27,28,33,34).   Assessment of cost-effectiveness was often limited by 
incomplete assessment of the cost of the intervention or health resource use (29).  
Even when improvements in quality of life were found, the high cost associated with 
the intervention meant that the cost per quality adjusted life year gained was very 
large (33,34). 
This%is%an%Accepted%Manuscript%of%an%article%published%by%Taylor%&%Francis%in%Amyotrophic%Lateral%Sclerosis%and%
Frontotemporal%Degeneration%on%30th%March%2016,%available%online:%
http://www.tandfonline.com/doi/full/10.3109/21678421.2016.1165255.!
! 6!
 
The potential benefits and challenges of using technology to facilitate access to care 
in ALS differ from those in other diseases. ALS is uncommon disease requiring care 
from a multidisciplinary team of specialists who must address patientsÕ changing 
needs, as well as supporting the use of complex equipment including that used for 
ventilation and gastrostomy feeding.  Technology could allow a specialist team to 
care for patients throughout their disease regardless of patientsÕ ability to travel to the 
specialist centre.  However, to be successful it must be accessible to patients who may 
be frail, have severe disability or difficulties with communication.  
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Methods 
Our aim was to review the current technologies used to facilitate access to specialist 
care for patients with ALS and/or their carers.  Outcomes of interest included clinical 
and health resource impacts but, given the novelty and complexity of these 
technologies, we also included papers that described the feasibility and acceptability 
of the intervention and impact on burden and quality of life.   
 
Search strategy 
A search was conducted using Medline, Google Scholar and the Cochrane library up 
to the end of 2014. Three journals were hand searched: Journal of Telemedicine and 
Telecare, Telemedicine and e-health and the Amyotrophic Lateral Sclerosis and 
Frontotemporal Degeneration journal.  Relevant author, reference lists and citations 
from published articles were also scrutinised.   The keywords and MeSH terms used 
were: amyotrophic lateral sclerosis, motor neurone disease, neurology, telemedicine, 
telehealth, remote monitoring, web, app, internet, teleneurology, respiratory failure, 
ventilation.   
 
Selection criteria for review 
¥ Studies involving patients and/or carers of those with any form of ALS/motor 
neurone disease 
¥ Studies using technology that enabled communication between a patient or 
carer and the clinician who were not in the same location 
¥ Papers and conference abstracts reported in English describing original 
research or service evaluation where sufficient information was available 
about the intervention, population and outcome. 
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The quality of the study methodology was not an inclusion criteria because one aim 
was to identify the range and feasibility of interventions even if comparative trials 
were not available.  The PRISMA checklist was used to guide the analysis and 
reporting of results (35). 
 
 
Results 
The search strategy identified 445 academic references, of which 31 full text articles 
and one conference abstract were reviewed for eligibility (Figure 1).   Interventions 
and study designs were diverse so statistical analysis was not appropriate and 
narrative synthesis was undertaken. The results are summarised in Tables 1-3. 
 
Two uses for technology were identified: video conferencing (telemedicine) as an 
alternative to outpatient appointments and telehealth to monitor and manage patients 
with respiratory failure. A number of papers describing the use of internet sites for 
self-diagnosis, education and social networking were excluded as they did not involve 
communication with a care team (36).  Other telemedicine programmes were 
identified but were excluded from the review as no evaluations had been conducted 
(37,38).  No interventions involving carers of those with ALS were identified.    
 
Telemedicine 
Four services used videoconferencing (telemedicine) to facilitate case management 
(Table 1) (39-42).  These were all observational studies and no formal evaluation was 
available.   A Dutch study used an internet chat room and video link to enable four 
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patients to conduct individual consultations with a rehabilitation team (40).   
Discussing most aspects of care using telemedicine was acceptable to patients and 
reduced travel to hospital, but patients still expressed a preference for face-to-face 
consultations when discussing emotional and psychological topics, including end-of-
of-life decisions.  Two services in the United States reported that using telemedicine 
had avoided outpatient visits resulting in patient travel cost savings (41,42).  An 
Australian study described using telemedicine between a tertiary centre and local 
community hospitals to facilitate the care of patients living far from the ALS clinic 
(39).  The Australian telemedicine service focused on symptom control and end-of-
life care and enabled contact for an extra year with patients who would otherwise not 
have been able to access these services.  
 
Telehealth in respiratory failure in ALS 
 
Study characteristics 
12 papers were identified together describing five telehealth systems used to 
intensively manage patients with chronic respiratory failure as an alternative to 
outpatient appointments. Table 2 and 3 describes the study methods and results.  The 
interventions and studies are described first, following which the clinical, cost and 
feasibility outcomes are discussed. 
 
Study quality 
Only two trials were identified that involved ALS patients comparing telehealth to 
usual care. Only one was a randomised controlled trial, the author of which was 
contacted for information about the methods and results (43).  Another trial was 
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identified which was described as randomised but actually assigned patients on the 
basis of their geographic location (44,45).  Both trials have been included in this 
review but were assessed to have a high risk of bias (see Appendix 1) and neither was 
sufficiently powered to detect clinical or economic benefits in the ALS patients. The 
other papers identified were observational studies but have been included in the 
review because they describe the feasibility and potential economic impact of 
telehealth on the clinical service.  
 
Tele-assistance in patients with chronic respiratory failure  
An Italian rehabilitation service evaluated a complex telehealth system for patients 
with respiratory failure.  Pulse oximetry data was collected and patients were assessed 
weekly by a respiratory nurse with access to physicians and a 24-hour emergency 
helpline (46).  
 
A one-year randomised controlled trial involved 240 patients with chronic respiratory 
failure, 22 of whom had ALS and 50 of whom had other neurological disorders (43).  
101 patients used non-invasive ventilation and 43 used tracheostomy ventilation.  The 
primary outcome was rate of hospital admissions. Secondary outcomes included 
mortality, respiratory exacerbations, emergency room admissions and urgent general 
practitioner calls.  Patients were randomised to usual care (routine three-monthly 
hospital appointments) or to the telehealth service with no scheduled outpatient 
appointments.  
 
A five-year observational study of this telehealth service examined the staffing and 
financial impact of caring for 396 patients, 91 of whom had ALS (47).  Two papers 
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describe the use of this service in ALS patients alone: a pilot, non-randomised 
observation study (40 patients) and a five-year service evaluation (73 patients) 
(48,49).  It is unclear whether the same patients were involved in more than one of 
these studies.  These evaluations estimated the resources required to run the service 
and potential health resource savings.   
 
The same Italian telehealth system was used to monitor 39 patients with ALS to 
identify respiratory exacerbations which would trigger the provision of a mechanical 
insufflation-exsufflation device ÒCough AssistÓ (50).  12 patients with ALS received 
cough assist on 47 occasions.  The same group conducted a pilot study using long-
term monitoring of peak cough flow, oxygen saturations and symptoms to identify 
respiratory deterioration in 12 patients with ALS using non-invasive ventilation (51).   
The patient recorded these measures daily and reported bi-weekly via a telephone call 
to a physiotherapist.  
 
 
Home telemonitoring of non-invasive ventilation in patients with amyotrophic lateral 
sclerosis.  
A telehealth service based in Lisbon (Portugal) caring for ALS patients used 
telehealth in addition to usual clinics using data collected from NIV ventilators 
relayed to the clinical team via the internet.  A set of algorithms were developed to 
enable clinicians assess patients and schedule telephone calls or hospital visits (52).  
Forty patients with ALS commencing non-invasive ventilation were recruited into a 
pilot trial and economic evaluation prior to developing respiratory failure (44,45).   
The intervention was commenced when they started using NIV. Primary outcomes 
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were number of visits to hospital and number of ventilator setting changes needed to 
reach full compliance.  Whilst the trial was described as randomised, patients were 
assigned a study arm according to whether they lived within Lisbon (usual hospital 
appointments) or outside Lisbon (intervention: telehealth plus usual three monthly 
appointments)(44).  Furthermore, whilst limited clinical characteristics collected at 
baseline suggested the groups were similar, baseline health resource use, socio-
economic status and co-morbid diseases were not reported.  
 
Other feasibility studies 
Two other systems used telehealth to manage patients with ALS using NIV were 
described in feasibility studies.  Both services were felt to be feasible and acceptable 
to patients but no comparative trials of the services were identified (53,54).   
 
  
This%is%an%Accepted%Manuscript%of%an%article%published%by%Taylor%&%Francis%in%Amyotrophic%Lateral%Sclerosis%and%
Frontotemporal%Degeneration%on%30th%March%2016,%available%online:%
http://www.tandfonline.com/doi/full/10.3109/21678421.2016.1165255.!
! 13!
 Outcomes 
Clinical outcomes 
The Italian randomised controlled trial of 240 patients (22 of whom had ALS) 
reported that telehealth care was associated with significantly fewer hospitalisations, 
respiratory exacerbations and urgent calls to general practitioners (43).  Mortality and 
emergency room attendance rates did not differ significantly (43). These differences 
only reached significance in the group of patients with chronic obstructive pulmonary 
disease and no significant differences were detected in the 22 patients with ALS 
(although the study was not powered to detect a difference in this sub-group) (43).   
 
The Lisbon pilot trial reported that telehealth was associated with significantly fewer 
outpatient, emergency room and hospital visits, but conclusions should be made with 
caution given the limitations in methodology (44,45). There was a trend towards 
longer survival in the telehealth group, but median time between symptom onset and 
starting NIV was much longer in the telehealth group suggesting that these patients 
had a slower disease course than those in the control group.  Therefore these results 
may be due survival trend to baseline differences between the groups rather than any 
impact from the intervention. 
 
 
 
Cost  
The Italian randomised controlled trial was not powered to provide a cost-evaluation. 
They did suggested that given the significant reduction in hospitalisations in the 
telehealth group, the healthcare costs for patients using telehealth would be less, but 
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estimates were imprecise and no formal statistical comparison was possible (43,55). 
Half of all cost savings were due to a small difference in the low number of intensive 
care admissions (14 vs. 16) (43).  Given that there were no significant differences in 
outcomes in the ALS patients no cost savings were demonstrated (43). However, 
according to the five year analysis, cost savings were made as nurses took over the 
roles of physicians with one nurse able to manage a caseload of 25 patients costing an 
estimated !105-108 per patient per month (47,49). Cost savings were also reported 
when the same telehealth system was used to detect respiratory exacerbations to 
supply Cough Assist machines (50). The service was reported to have prevented 30 
hospital admissions which was estimated to be 59% cheaper than providing machines 
to all patients (50).   
 
In the Lisbon study (after adjusting for survival by dividing the total health costs by 
the number of days using NIV) healthcare costs in the telehealth group were 
significantly lower due to reduced inpatient and transport costs (44,45).  These results 
should be interpreted with caution as baseline characteristics differed and patients 
were assigned a study arm based on whether they lived in a rural or urban location - a 
factor that may independently influence health resource use. 
  
Quality of life, feasibility, acceptability and adherence 
None of the studies examined patient or carer burden or quality of life. The Lisbon 
study examined patientsÕ attitudes to the service: 93% of patients rating the service as 
ÒgoodÓ or Òvery goodÓ but only 36% of patients considered it to be a method of 
improving their life (48).   The reasons for this are not described, but these telehealth 
regimes were very intensive requiring patients to make frequent contact with the ALS 
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team.  The Italian study found that the majority of contacts were routine and did not 
result in a change in their care which may be demoralising to service users (49).  
Dropout was low, but the author of the Italian study suggested (in personal 
correspondence) that it was difficult to recruit ALS patients to the Italian trial because 
they wanted to use the telehealth service and did not wish to be randomised to the 
control arm (43,55).   
 
Despite the intensity of the regimes, factors that might influence patient adherence 
were not explored.  Poor patient adherence impacted on the success of the service in 
the telehealth system monitoring cough to detect respiratory exacerbations.  The 
system was so complex for the patients that they failed to adhere to the telehealth 
regime and did not provide sufficient readings for the system to detect a change in 
their condition (51).  In another feasibility study using telehealth to support NIV use, 
those who adhered well to the telehealth regime experienced a reduction in 
hospitalisations, whereas those who failed to send data regularly experienced an 
increase in hospitalisations (54). This requires further investigation as baseline 
hospitalisation rates were much higher in the ÒgoodÓ adherence group compared to 
the ÒpoorÓ group and no account was taken of other factors associated with 
compliance that may independently influence patient outcome (e.g. disease severity).  
 
Discussion 
There is limited evidence to recommend the use of telemedicine or telehealth in the 
care of patients with ALS.   However, larger evaluations of telemedicine in other 
neurological diseases do suggest that telemedicine could be an acceptable alternative 
to face-to-face consultation, particularly when travelling to clinic is difficult (21,56-
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58). Using telehealth as an alternative to clinic visits appears technically feasible but 
further research needs to establish its safety and effectiveness. Telehealth and 
telemedicine could also be useful as an addition to specialist outpatient clinics.   For 
example, telehealth could be used to better monitor patients between clinics.   
Telemedicine could provide access to specialist services between visits such as 
counselling or speech therapy or by completing some of the consultation at home thus 
reducing the duration of clinic visits.   
 
With technology costs falling, if interventions do reduce health resource use they 
could be cost effective.  The models of telehealth described in this review are 
intensive and require a large number of specialist staff at considerable cost, but 
monitoring could become more automated, reducing staff burden and making systems 
more affordable. 
 
Telehealth and telemedicine services are complex interventions consisting of many 
component parts and their ability to bring about change depends on many factors (32).  
Whilst further adequately powered experimental trials are important, future research 
must use additional methodologies appropriate for developing and evaluating such 
complex interventions. Using approaches such as modelling or observational studies 
of interventions in practice may better identify the potential impacts on patients, staff 
and the clinical service, complementing any experimental studies.  Such 
methodologies will also contribute to an understanding of factors influencing success 
of interventions such as the structure of different ALS services and the attitude of the 
patients and staff towards using new interventions.    
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It is also important to determine how the effects of an intervention can be 
comprehensively measured.  This should include clinical and quality of life outcomes 
as well as patient and carer burden, as interventions which increase the medicalisation 
of patientsÕ lives can increase burden and could have a negative effect on quality of 
life (59,60).  
 
Conclusion 
 
Development of successful tele- services requires a better understanding of the 
beneficial aspects of the traditional ALS services and how these could be delivered 
using technology.  There is currently limited evidence to suggest that using telehealth 
or telemedicine to improve access to specialist care in ALS improves outcomes or 
reduces costs. However, the inherent challenges of managing patients with ALS is a 
reason to support further exploration of how to successfully incorporate technology 
into ALS specialist services. Any future studies should ensure that all relevant 
impacts of such technology interventions are captured, enabling successful evaluation 
and when appropriate, future implementation.  
 
 
Table and Figures 
 
Figure 1: Flow diagram of the literature search 
Table 1: Telemedicine studies 
Table 2: Telehealth studies 
Table 3: Telehealth results and limitations  
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Appendix 1: Assessment of bias summary 
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Table&1:&telemedicine&studies&
&
Title Year Intervention Study design N.o. of 
patients 
Outcomes Limitations 
Tele-treatment of 
patients with 
amyotrophic lateral 
sclerosis (ALS)  
2006 Information website + 
scheduled access to clinician 
via chat room + video 
conferencing from tertiary 
hospital to home 
Pilot, feasibility, 
acceptability 
n=4 Acceptable topics for discussion: symptoms 
(75%), treatment options within the MND 
team (75%), first line and treatment options 
elsewhere (100%), progress (100%)  
Less preferred topics: acceptance/coping 
with MND (50%), preferences for end of life 
(25%) 
Patients who become 
more disabled were 
unable to use 
equipment.    
All were young 
patients with computer 
experience 
Early and innovative 
symptomatic care to 
improve quality of life of 
ALS patients at 
Cleveland VA ALS 
Center 
2013 Video conferencing from 
tertiary hospital to home 
Service 
evaluation  
n=12 Predicted $34 137 saving over two years in 
patient travel expenses 
No formal evaluation 
Comprehensive care and 
home telehealth for 
veterans with ALS  
2013 Video conferencing from 
tertiary hospital to home 
Service 
evaluation  
n=17 Improved patient satisfaction and reduced 
driving time and travel costs (no figures 
provided) 
No formal evaluation 
Telehealth in motor 
neurone disease  
2014 Telemedicine from tertiary 
hospital to local community 
hospital/health centre 
Service 
evaluation  
n=38 Allowed patients who could not travel 
contact with MND clinic for approx. 1 extra 
year 
No formal evaluation 
 
Table&2:&telehealth&studies&
Title Year Intervention Study design Control Time N.o of patients Patient 
characteristics Total With 
MND 
Tele-assistance in chronic respiratory failure patients 
Tele-assistance in patients with amyotrophic lateral sclerosis: 
long term activity and costs  
2012  Observational None Up to 5 
years 
n=73 n=73 25% TV, 25%NIV  
34% PEG  
A pilot trial of telemedicine-assisted, integrated care for 
patients with advanced amyotrophic lateral sclerosis and 
their caregivers  
2010 Telehealth: 02 either intermittent or continuous oximetry 
telemetry  
Observational    None 1-12 
months 
n=40 n=40 30% TV, 
48% NIV 
50% PEG 
Tele-assistance in chronic respiratory failure: patients' 
characterization and staff workload of 5-year activity  
2010 Clinical service: Specialist nurse weekly scheduled calls 
using clinical assessment algorithms + emergency telephone 
calls with physician + out-of-hours call centre who could 
contact physician if required.  No routine outpatient clinics 
Observational None Up to 5 
years 
n= 396 n=91 77-83% ventilated  
Tele-assistance in chronic respiratory failure patients: a 
randomised clinical trial  
2009 RCT 3 month 
clinic 
1 year n= 240 n=22 18% TV 
43% NIV   
A pilot study of nurse-led, home monitoring for patients with 
chronic respiratory failure and with mechanical ventilation 
assistance  
2006   Feasibility None 6 
months 
n=45 n=5 31% TV 
52% NIV 
At home and on demand mechanical cough assistance 
program for patients with amyotrophic lateral sclerosis  
2010 Telehealth + clinical service as service described above             
CA for respiratory exacerbations 
Feasibility None 9-16 
months 
n= 39 n= 39 31% TV 
38% NIV  
Home telemonitoring of non-invasive ventilation in patients with amyotrophic lateral sclerosis 
Economic cost of home-telemonitoring care for BiPAP-
assisted ALS individuals  
2012 Telehealth: NIV ventilators monitoring usage + pattern of 
respiration + facility to adjust ventilator settings                         
Clinical service: weekly review of TH data + predefined 
alerts (variations from +/- 1 SD of the mean values of IPAP, 
expiratory positive air pressure, inspiratory/ expiratory ratio, 
backup rate, inspiratory sensitivity, expiratory sensitivity 
and rise time) to alert clinicians to clinical problems + 24 
hour helpline + 3 monthly clinic  
Pseudo-
randomised 
pilot 
3 month 
clinic 
Up to 3 
years  
n=40 n=40 100% NIV, 
0% gastrostomy            
Home telemonitoring of non-invasive ventilation decreases 
healthcare utilisation in a prospective controlled trial of 
patients with amyotrophic lateral sclerosis  
2010 
Implementation of a wireless device for real-time telemedical 
assistance of home-ventilated amyotrophic lateral sclerosis 
patients: a feasibility study  
2010 Feasibility None Not 
stated 
Not stated 100% NIV 
Other telehealth studies 
Pilot study for home monitoring of cough capacity in 
amyotrophic lateral sclerosis: A case series 
2014 Telehealth: 02, PCEF,  symptoms reported via 
email/telephone                                                                        
Clinical service: Bi-weekly telephone support 
Pilot, 
observational 
None 9 
months 
n=12 n=12 100% NIV 
Telemonitoring in chronic ventilatory failure: a new model of 
surveillance, a pilot study  
2012 Telehealth: 02, pulse, spirometer, CO2, BP, ventilator 
flow, pressure and volumes, overnight 02 
Clinical service: 24-hour helpline. No routine calls 
Observational 
feasibility 
Historic 
data 
2 years n= 16 n= 3 31% TV 
69% NIV  
A telemedicine instrument for home monitoring of patients 
with chronic respiratory diseases  
2007 Telehealth: 02, pulse, spirometer, capnometer, BP, 
ventilator air flow, pressure and volumes 
Feasibility None Not 
stated 
n=15 n=15 Using NIV/TV 
 
TH telehealth, TV tracheostomy ventilation, NIV non-invasive ventilation, CA cough assist/mechanical insufflation-exsufflation, O2  oxygen saturations using finger probe, PCEF peak cough expiratory force, ICU intensive care unit, PEG percutaneous gastrsostomy, BP blood pressure, 
FVC forced vital capacity, RCT randomised controlled trial 
Table&3:&telehealth&results&and&limitations&
TH telehealth, CA- cough assist/mechanical insufflation-exsufflation, ICU intensive care unit, SD standard deviation, FVC forced vital capacity.  Figures reported as mean and standard deviation (SD) 
Title Clinical outcomes Resource use / economic evaluation /feasibility Limitations 
Tele-assistance in chronic respiratory failure patients 
Tele-assistance in patients with amyotrophic lateral 
sclerosis: long term activity and costs  
  Estimated cost of service per patient per month: !105 
1 nurse can manage 25 patients per month  
  
A pilot trial of telemedicine-assisted, integrated care for 
patients with advanced amyotrophic lateral sclerosis 
and their caregivers  
  Estimated cost of service per patient per month: !118                                                      
19 (96%) rated TH good/very good                  
7 (36%) thought TH would improve their life     
  
Tele-assistance in chronic respiratory failure: patients' 
characterization and staff workload of 5-year activity  
  Cost per patient per month !56 in year 5 (ALS patients cost more) 
Physicians' work decreased: reduced salary costs by 39% in year 1 
 
Tele-assistance in chronic respiratory failure patients: 
a randomised clinical trial  
TH associated with: 
Fewer hospitalisations (TH 0.14 SD 0.21 per month controls 
0.22 SD 0.24, p=0.01)             
Increased chance of avoiding hospital admission (p=0.004).  
Fewer respiratory exacerbations (TH 0.78 SD 0.77 per month 
control 0.23 SD 0.38 p=0.0001)  
Fewer urgent general practitioner calls (TH 0.22 SD 0.34 per 
month, control 0.07 SD 0.17 p=0.002)                       
No difference in mortality, emergency room visits 
No difference in any outcome in 22 MND patients 
Estimated health costs lower in the TH group (TH mean !8907 SD !17580, control 
!14728, !28694) due to reduced hospitalisations  
No differences in costs in the 22 MND patients 
High risk of 
bias.                   
Study not 
powered to 
compare costs.       
Half cost 
savings due to a 
slightly smaller 
number of ICU 
admissions  
A pilot study of nurse-led, home monitoring for patients 
with chronic respiratory failure and with mechanical 
ventilation assistance  
  System was feasible once problems with transmitting data were resolved by 
improved training of patients and carers 
  
At home and on demand mechanical cough assistance 
program for patients with amyotrophic lateral sclerosis 
12 patients used CA for 47 respiratory episodes    
30 hospitalisations were avoided  
Estimated cost of service per patient per month: !403 SD !420: 59% less than for 
providing continuous CA  
No clinical 
outcomes  
Home telemonitoring of non-invasive ventilation in patients with amyotrophic lateral sclerosis 
Economic cost of home-telemonitoring care for BiPAP-
assisted ALS individuals  
  TH associated with: no difference in estimated mean annual hospital costs 
(outpatient and inpatient encounters)   
TH: lower estimated costs of annual hospital service + patient transport + respiratory 
equipment rental (TH !8186 SD 6553, control !44143 SD 11316 p=0.005)   
Estimated total saving of !700 per patient per year 
No carer cost savings 
High risk of 
bias 
Study not 
randomised.           
Baseline 
characteristics 
differed.                 
No baseline 
economic data.  
Home telemonitoring of non-invasive ventilation 
decreases healthcare utilisation in a prospective 
controlled trial of patients with amyotrophic lateral 
sclerosis  
TH associated with: 
Fewer outpatient visits (TH 3.02, control 9.02 p<0.0001) 
Fewer emergency room visits  (TH 0.11, control 0.58 p<0.0001) 
Fewer hospital admissions  (TH 0.06, control 0. 37 p<0.001)  
No significant difference in survival 
 
Implementation of a wireless device for real-time 
telemedical assistance of home-ventilated amyotrophic 
lateral sclerosis patients: a feasibility study  
  System was "feasible"   
Other telehealth studies       
Pilot study for home monitoring of cough capacity in 
amyotrophic lateral sclerosis: A case series 
  The system was unfeasible as compliance was poor: 22% at 6-9 months due to the 
complex demands of the regime on patients. 
  
Telemonitoring in chronic ventilatory failure: a new 
model of surveillance, a pilot study  
73% less hospitalisations if "good" compliance (rate prior 1.222 
SD 1.09 after 0.333 SD 0.5)                                                   
100% increase in hospitalisations if "poor" compliance (prior 
0.285 SD 0.487 after 0.571 SD 1.133) 
56% patients had good adherence 
Definition of intervention adherence unclear 
Baseline 
hospitalisation 
rates in groups  
different. 
A telemedicine instrument for home monitoring of 
patients with chronic respiratory diseases  
 Technically "feasible"   
Appendix(1:(Assessment(of(bias(summary(
(
(
(
Study Adequate 
sequence 
generation  
Allocation 
concealment  
Blinding  Incomplete 
outcome 
data 
addressed 
Free of 
selective 
reporting  
Free of 
other bias  
Tele-assistance in chronic respiratory 
failure patients: a randomised clinical 
trial  
Low$risk$ Low$risk$ High$risk$ High$risk$ High$risk$ Unclear$
Economic cost of home-telemonitoring 
care for BiPAP-assisted ALS 
individuals  
High$risk$ High$risk$ High$risk$ Unclear$ High$risk$ Unclear$
Home telemonitoring of non-invasive 
ventilation decreases healthcare 
utilisation in a prospective controlled 
trial of patients with amyotrophic 
lateral sclerosis  
 
Based on the Risk of Bias Tool from the Cochrane Handbook for Systematic Reviews of Interventions(
